Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2007-2-20
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1526-632X
pubmed:author
pubmed:issnType
Electronic
pubmed:day
20
pubmed:volume
68
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
624; author reply 624
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:17310043-Aged, pubmed-meshheading:17310043-Alzheimer Disease, pubmed-meshheading:17310043-Amnesia, pubmed-meshheading:17310043-Apolipoprotein E4, pubmed-meshheading:17310043-Apolipoproteins E, pubmed-meshheading:17310043-Cognition Disorders, pubmed-meshheading:17310043-DNA Mutational Analysis, pubmed-meshheading:17310043-Diagnosis, Differential, pubmed-meshheading:17310043-Female, pubmed-meshheading:17310043-Gene Frequency, pubmed-meshheading:17310043-Genetic Predisposition to Disease, pubmed-meshheading:17310043-Genetic Testing, pubmed-meshheading:17310043-Genotype, pubmed-meshheading:17310043-Heterozygote, pubmed-meshheading:17310043-Humans, pubmed-meshheading:17310043-Male, pubmed-meshheading:17310043-Memory Disorders, pubmed-meshheading:17310043-Phenotype, pubmed-meshheading:17310043-Predictive Value of Tests
pubmed:year
2007
pubmed:articleTitle
The effect of APOE genotype on clinical phenotype in Alzheimer disease.
pubmed:publicationType
Letter, Comment